Skip to main content

Table 1 Patient clinical and pathological characteristic

From: Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma

Characteristics

All patients (%)

Patients with local recurrence (%)

Patients without local recurrence (%)

P value

Patient number

389

73 (18.8)

316 (81.2)

 

Median age (range)

69 (35-88)

70 (37-85)

69 (35-88)

 

Age group

   

0.620

 < 70

202 (51.9)

36 (49.3)

166 (52.5)

 

 ≥ 70

187 (48.1)

37 (50.7)

150 (47.5)

 

Gender

   

0.727

 Male

190 (48.8)

37 (50.7)

153 (48.4)

 

 Female

199 (51.2)

36 (49.3)

163 (51.6)

 

Site

   

0.393

 Left

185 (47.6)

38 (52.1)

147 (46.5)

 

 Right

204 (52.4)

35 (47.9)

169 (53.5)

 

Location

   

0.042

 Pelvic

212 (54.5)

32 (43.8)

180 (57.0)

 

 Ureter

177 (45.5)

41 (56.2)

136 (43.0)

 

Concomitant bladder tumor

   

0.192

 Yes

42 (10.8)

11 (15.1)

31 (9.8)

 

 No

347 (89.2)

62 (84.9)

285 (90.2)

 

Tumor type

   

0.599

 Complete TCC

278 (71.5)

54 (74.0)

224 (70.9)

 

 TCC with other differentiation

111 (28.5)

19 (26.0)

92 (29.1)

 

Surgical procedure

   

0.088

 Laparoscopic nephroureterectomy

326 (83.8)

57 (78.1)

269 (85.1)

 

 Open nephroureterectomy

63 (16.2)

16 (21.9)

47 (14.9)

 

Lymph vascular invasion

   

0.009

 Yes

58 (14.9)

18 (24.7)

40 (12.7)

 

 No

331 (85.1)

55 (75.3)

276 (87.3)

 

Tumor grade

   

0.000

 G1

6 (1.6)

0

6 (1.9)

 

 G2

209 (54.4)

17 (23.6)

192 (61.5)

 

 G3

169 (44.0)

55 (76.4)

114 (36.5)

 

Pathological stage

   

0.000

 T1

125 (32.6)

9 (12.3)

116 (36.7)

 

 T2

121 (31.5)

15 (20.5)

105 (33.3)

 

 T3

129 (33.6)

48 (65.8)

87 (27.5)

 

 T4

9 (2.3)

1 (1.4)

8 (2.5)

 

Lymph node detection

   

0.000

 No

316 (81.2)

48 (65.8)

268 (84.8)

 

 Yes

73 (18.8)

25 (34.2)

48 (15.2)

 

Lymph node involvement

   

0.000

 Nx

316 (81.2)

48 (65.8)

268 (84.8)

 

 N0

43 (11.1)

9 (12.3)

34 (10.8)

 

 N1

11 (2.8)

4 (5.5)

7 (2.2)

 

 N2

19 (4.9)

12 (16.4)

7 (2.2)

 

Multifocality

   

0.013

 No

321 (82.5)

53 (72.6)

268 (84.8)

 

 Yes

68 (17.5)

20 (27.4)

48 (15.2)

 

Margin

   

0.189

 Positive margin

12 (3.1)

4 (5.5)

8 (2.5)

 

 Negative margin

377 (96.9)

69 (94.5)

308 (97.5)

 

Adjuvant radiotherapy

   

0.014

 Yes

57 (14.7)

4 (5.5)

53 (16.8)

 

 No

332 (85.3)

69 (94.5)

263 (83.2)

Â